Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
2,552
Views
4
CrossRef citations to date
0
Altmetric
Oncology

How accurate are the longer-term projections of overall survival for cancer immunotherapy for standard versus more flexible parametric extrapolation methods?

Miranda Coopera BresMed Health Solutions, Sheffield, UKORCID Iconhttps://orcid.org/0000-0001-8814-5500
ORCID Icon,
Sarah Smitha BresMed Health Solutions, Sheffield, UKORCID Iconhttps://orcid.org/0000-0003-3380-4411
ORCID Icon,
Troy Williamsb BresMed Health Solutions, Las Vegas, NV, USAORCID Iconhttps://orcid.org/0000-0002-1540-6922
ORCID Icon &
Raquel Aguiar-Ibáñezc Merck Canada Inc, Kirkland, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3839-6966
ORCID Icon
Pages 260-273 | Received 09 Sep 2021, Accepted 14 Jan 2022, Published online: 11 Feb 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ivo Abraham, Kenneth K. C. Lee & Mike Gregg. (2023) Journal of Medical Economics in review: high impact articles from 2022. Journal of Medical Economics 26:1, pages 303-307.
Read now

Articles from other publishers (3)

Hanqiao Shao, Mingye Zhao, Ai-Jia Guan, Taihang Shao, Dachuang Zhou, Guo Yu & Wenxi Tang. (2024) A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer. BMC Medicine 22:1.
Crossref
Taihang Shao, Mingye Zhao, Leyi Liang, Lizheng Shi & Wenxi Tang. (2023) Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067. PharmacoEconomics - Open 7:3, pages 383-392.
Crossref
Taihang Shao, Mingye Zhao, Leyi Liang & Wenxi Tang. (2022) A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer. Frontiers in Immunology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.